Skip to main content
Abliva logo

Abliva — Investor Relations & Filings

Ticker · ABLI ISIN · SE0002575340 LEI · 5493005YV22OTMUHZ183 ST Manufacturing
Open in API
Filings indexed 594 across all filing types
Latest filing 2022-04-19 AGM Information
Country SE Sweden
Listing ST ABLI

About Abliva

https://abliva.com

Abliva is a biopharmaceutical company that discovers and develops medicines for the treatment of primary mitochondrial diseases. These are rare, congenital, and often severe genetic disorders that occur when the cell's energy converters, the mitochondria, are dysfunctional. The company's research and development is focused on creating novel therapies aimed at restoring mitochondrial function and addressing the significant unmet medical needs of patients. Abliva's primary goal is to deliver treatments that provide meaningful clinical benefits for individuals suffering from these debilitating conditions.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting of Abliva AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of Annual General Meeting of Abliva AB (publ)". It details the date, time, location, registration procedures, proposed agenda items (including election of chair, approval of accounts, remuneration report, election of board/auditor, and amendments to Articles of Association), and proposed resolutions for the meeting. This content perfectly matches the definition of AGM Information (AGM-R). It is not a full 10-K, an earnings release, or a proxy statement (PSI), but the formal notice convening the Annual General Meeting.
2022-04-19 English
Earnings Release 2021
Earnings Release Classification · 1% confidence The document is titled "Bokslutskommuniké januari – december 2021" (Year-end Report/Financial Statement Communication January – December 2021) and contains a CEO's summary, key events for the year, detailed financial information for Q4 and the full year (Net Sales, Profit before tax, EPS), and strategic outlook. The presence of full-year financial figures, a CEO review, and detailed operational updates strongly indicates this is an official annual financial report. Although it is presented as a 'communication' (kommuniké), its comprehensive nature covering the entire fiscal year and including detailed financial tables aligns best with the definition of an Annual Report (10-K), even if the specific regulatory filing code '10-K' is not explicitly mentioned, as this is the standard classification for comprehensive annual financial disclosures. FY 2021
2022-02-22 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Year-End Report January – December 2021' and contains comprehensive financial data, including income statements, loss per share, and management commentary on business performance and outlook for the fiscal year. It is a substantive financial report covering a period shorter than a full fiscal year (in the context of the quarterly breakdown) and the full year, fitting the definition of an Interim/Quarterly Report (IR). FY 2021
2022-02-22 English
Resolution at the Extraordinary General Meeting in Abliva AB (publ)
Share Issue/Capital Change Classification · 1% confidence The document explicitly states it contains the 'Resolution at the Extraordinary General Meeting in Abliva AB (publ)'. It details the approval of a resolution regarding a directed issue of convertibles (a financing/capital structure event) voted upon at an Extraordinary General Meeting (EGM). While it involves capital structure changes (CAP) and shareholder voting results (DVA), the primary context is the formal outcome of a shareholder meeting. Since the document is the official summary of the resolutions passed at the EGM, it aligns best with the general category for shareholder meeting outcomes or related corporate actions. Given the options, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most specific fit for reporting the outcome of a general meeting resolution, even though the resolution itself concerns capital raising (CAP). However, since the text is a summary of the *resolution* passed at the EGM, and not just the voting results, and it details a significant financing event, it could also be argued as CAP. Looking closely at the definitions, DVA covers 'Official results from shareholder votes at any general meeting (AGM or EGM)'. This document is the official summary of what was resolved. It is not a standard 10-K, ER, or IR. It is a specific announcement about an EGM resolution. I will classify it as DVA as it reports the outcome of the EGM.
2022-01-14 English
Beslut vid extra bolagsstämma i Abliva AB (publ)
Share Issue/Capital Change Classification · 1% confidence The document is titled "Beslut vid extra bolagsstämma i Abliva AB (publ)" (Decision at the Extraordinary General Meeting of Abliva AB (publ)). It details a specific resolution passed at this meeting: the approval of a directed convertible bond issuance. This content directly relates to shareholder decisions and corporate governance outcomes from a general meeting. Although it announces a financing event (convertible loan), the primary context and structure revolve around the decisions made at the EGM. The closest fit among the provided codes is AGM-R (AGM Information), as an Extraordinary General Meeting (EGM) decision summary is functionally similar to AGM materials, focusing on shareholder-approved actions. Since the document is a summary of the decisions made, and not just a general regulatory announcement (RNS) or a financing announcement (CAP) in isolation, AGM-R is the most appropriate classification for EGM outcomes.
2022-01-14 Swedish
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document details a change in shareholding and voting rights for an individual (John Fällström) in a company (Abliva AB). It explicitly shows the 'Before the transaction' and 'After the transaction' quantities of shares and voting rights, resulting in a new percentage (5.45943%) that crosses a reporting threshold (5%). This type of filing, reporting changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). The structure is typical of regulatory notifications regarding ownership changes.
2021-12-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.